BUPRENORPHINE- buprenorphine solution 
PAYLESS COMPOUNDERS, LLC

----------

buprenorphine inj MDV 0.6mg/mL
BUPRENORPHINE 
buprenorphine solution
Product Information
Product TypeANIMAL COMPOUNDED DRUGItem Code (Source)NDC:70022-004
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUSDEA ScheduleCIII    
Reporting Period20151006-20160405
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BUPRENORPHINE HYDROCHLORIDE (UNII: 56W8MW3EN1) (BUPRENORPHINE - UNII:40D3SCR4GZ) BUPRENORPHINE0.6 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
MANNITOL (UNII: 3OWL53L36A)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70022-004-1010 mL in 1 VIAL, MULTI-DOSE; Number of Units = 10
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/06/2015
Labeler - PAYLESS COMPOUNDERS, LLC (031728341)
Establishment
NameAddressID/FEIBusiness Operations
PAYLESS COMPOUNDERS, LLC604160239outsourcing animal drug compounding

Revised: 10/2015
Document Id: f2fc6aea-1e38-4553-9228-34d360d01070
Set id: c385095b-152a-45fd-8c49-3e44493e9a00
Version: 2
Effective Time: 20151021
 
PAYLESS COMPOUNDERS, LLC